Actis’s investment of 21% equity stake in Integrated Diagnostics Holdings’ operations in Egypt for USD 113 million

Lead party: Actis LLP (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Integrated Diagnostics Holdings PLC (public company) · Sector: Healthcare, Specialty Healthcare Providers · Countries of operation: Egypt, Sudan, Mauritius, Nigeria Transaction type: Investment · Asset class: Private Equity · Strategy: Strategic Minority · Instrument: Equity ·…


Lead party: Actis LLP (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Integrated Diagnostics Holdings PLC (public company) · Sector: Healthcare, Specialty Healthcare Providers · Countries of operation: Egypt, Sudan, Mauritius, Nigeria

Transaction type: Investment · Asset class: Private Equity · Strategy: Strategic Minority · Instrument: Equity · Deal amount: US$113m · Equity stake: 0.21% · Implied EV: US$538.1m

Lead investor/buyer: Actis LLP · Investors/buyers: Actis LLP

Legal advisers: not identified in the source record.

Source: announced 16 December 2014. Original announcement: act.is.